摘要
据最新报道,α-甲酰基辅酶A消旋酶(AMACR)作为一个重要的固体肿瘤标志物,是设计抗肿瘤剂的一个有吸引力的靶点,其为一种线粒体和过氧化物酶体酶,在胆固醇代谢产物和支链脂肪酸的氧化过程中起着核心作用。人AMACR的三维结构仍然未知。现有研究已报告,采用基于1x74a模板的建模器和不同造型的模型服务器建立同源模型。采用各种可行的程序如PROCHECK, ERRAT, ProSA等对三维模型的生成进行了验证和评价,为找到AMACR强效抑制剂进行对接研究,在对接研究中,利用化合物的活性对这种酶的其他生物进行了分析。在抑制剂研究中,2-甲基肉豆蔻-辅酶A有效结合此酶,并抑制此酶通过氢键与口袋关键残基的相互作用。此外,进行分子动力学模拟,以检验AMACR /2-甲基肉豆蔻酰基辅酶A配合物的稳定性。结果显示,示出了配体和酶的高亲和力,以及在动态条件下氢键相互作用的稳定性。因此,2-甲基肉豆蔻酰基辅酶A已被认为是一个很有前途的先导化合物,为抗AMACR方面一个新的抑制剂。
关键词: α-甲基酰基辅酶A消旋酶,结合自由能计算,智人,同源建模,分子对接,分子动力学,前列腺癌
Current Cancer Drug Targets
Title:Structural Characterization of Alpha-methylacyl-CoA Racemase: Comparative Structural Modeling, Molecular Docking and Dynamic Simulations Studies
Volume: 15 Issue: 9
Author(s): Sumra Wajid Abbasi and Syed Sikander Azam
Affiliation:
关键词: α-甲基酰基辅酶A消旋酶,结合自由能计算,智人,同源建模,分子对接,分子动力学,前列腺癌
摘要: α-Methylacyl-CoA racemase (AMACR) has recently been reported as a vital solid tumor marker and is an attractive target for designing anti-tumor agents. It is a mitochondrial and peroxisomal enzyme which plays a central role in the oxidation of cholesterol metabolites and branched chain fatty acids. The three dimensional structure of human AMACR is still unknown. In the current study, homology model using Modeller and different modelling servers based on 1X74A as template is reported. The three dimensional model generated was validated and evaluated using various available programs like PROCHECK, ERRAT, ProSA energy plots, etc. In order to find potent inhibitors of AMACR, a docking study using compounds reported to be active against this enzyme of other organisms was conducted. Among the studied inhibitors, 2-methylmyristoyl- CoA effectively binds to and inhibits the enzyme by means of hydrogen bond interactions with the key residues of pocket. Moreover, molecular dynamics simulation was carried out to check the stability of AMACR/2-methylmyristoyl-CoA complex. The results illustrated the ligand’s high binding affinity with enzyme and the stability of hydrogen bond interactions in dynamic condition. Hence, 2-methylmyristoyl-CoA has been suggested to be a promising lead compound for the design of new inhibitors against AMACR.
Export Options
About this article
Cite this article as:
Sumra Wajid Abbasi and Syed Sikander Azam , Structural Characterization of Alpha-methylacyl-CoA Racemase: Comparative Structural Modeling, Molecular Docking and Dynamic Simulations Studies, Current Cancer Drug Targets 2015; 15 (9) . https://dx.doi.org/10.2174/156800961509151110145430
DOI https://dx.doi.org/10.2174/156800961509151110145430 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Importance of Thymoquinone, Sulforaphane, Phloretin, and Epigallocatechin
and their Health Benefits
Letters in Drug Design & Discovery A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers
Current Medicinal Chemistry Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis
Current Pharmaceutical Biotechnology Molecular Switch of AhR in Repression or Activation of Stem Cell Signaling
Current Signal Transduction Therapy The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Sensor/Effector Drug Design with Potential Relevance to Cancer
Current Pharmaceutical Design A Mechanistic Approach on Structural, Analytical and Pharmacological Potential of Beta-sitosterol: A Promising Nutraceutical
Current Nutrition & Food Science ImmunemiR - A Database of Prioritized Immune miRNA Disease Associations and its Interactome
MicroRNA Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy
Current Topics in Medicinal Chemistry Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor
Recent Patents on Anti-Cancer Drug Discovery Recent Studies of Antioxidant Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments
Current Topics in Medicinal Chemistry 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Recent Patents on Transglutaminase Production and Applications: A Brief Review
Recent Patents on Biotechnology Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells
Anti-Cancer Agents in Medicinal Chemistry Genistein Down-Regulates miR-223 Expression in Pancreatic Cancer Cells
Current Drug Targets